Sale of MatTek Corp (US) to Sartorius Lab Holding GmbH (DE) – USD 80 million

DNB Carnegie acted as financial adviser to BICO in the divestment of MatTek to Sartorius. MatTek is a US-based market-leading provider of 3D microtissue models and primary cells for in-vitro testing, which offers faster, more cost-efficient, and reproducible alternatives to animal testing. MatTek was acquired by BICO in March 2021. Visikol, also a BICO company, is specializing in advanced imaging and digital pathology. During 2024, the business operations of Visikol were merged and operationally integrated into MatTek.